{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T23:49:49Z","timestamp":1694389789369},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Clinical Psychopharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/yic.0b013e3283611d03","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T09:45:47Z","timestamp":1365759947000},"page":"1","source":"Crossref","is-referenced-by-count":3,"title":["A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder"],"prefix":"10.1097","author":[{"given":"Karen","family":"Tourian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["International Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/YIC.0b013e3283611d03","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:28:40Z","timestamp":1620977320000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.lww.com\/00004850-900000000-99807"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1097\/yic.0b013e3283611d03","relation":{},"ISSN":["0268-1315"],"issn-type":[{"value":"0268-1315","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}